Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough



Rating:

Share or cite this content

Citations should be made in the following way:
K. Ramaraju (Coimbatore (Tamil Nadu), India), R. Sankaran (Coimbatore (Tamil Nadu), India), A. Kaza (Coimbatore (Tamil Nadu), India), T. Sairam (Coimbatore (Tamil Nadu), India). Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization.. 3117

Member's Comments

No comment yet.

Related content which might interest you: Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Inflammatory changes, recovery and recurrence at COPD exacerbation Source: Eur Respir J 2007; 29: 527-534 Year: 2007 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017 Distinct clinical phenotypes of airways disease defined by cluster analysis Source: Eur Respir J 2009; 34: 812-818 Year: 2009 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Inflammatory phenotypes of COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Clinical determinants of exacerbations in severe, early-onset COPD Source: Eur Respir J 2007; 30: 1124-1130 Year: 2007 Microbiological and inflammatory patterns in severe exacerbated COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 Impact of exacerbations in the natural course of COPD Source: Eur Respir Monogr 2013; 60: 84-95 Year: 2013 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014